<DOC>
	<DOCNO>NCT01030666</DOCNO>
	<brief_summary>Study Hypothesis : The administration 200 mg doxycycline day 7 day regenerative periodontal therapy infrabony defect improve result therapy ( clinical vertical attachment gain [ CAL-V ] , bony fill ) reduce postoperative flap dehiscence defect exposure . In 90 patient one infrabony defect shall treat regenerative technique ( guide tissue regeneration [ GTR ] , enamel matrix derivative [ EMD ] ) . Prior , 6 , 12 , 24 month surgery clinical measurement ( Plaque Index [ PlI ] , probe depth [ PD ] , vertical clinical attachment level [ CAL-V ] , Gingival Index [ GI ] ) standardize radiograph obtain .</brief_summary>
	<brief_title>Effect Postsurgical Systemic Doxycycline After Regenerative Periodontal Therapy</brief_title>
	<detailed_description>Patients From April 2007 February 2009 patient undergoing periodontal treatment Department Periodontology , Center Dental , Oral , Maxillofacial Medicine ( Carolinum ) , Johann Wolfgang Goethe-University Frankfurt/Main Section Periodontology , Department Conservative Dentistry , Clinic Oral , Dental Maxillofacial Diseases , University Hospital Heidelberg screen study . Patients method study describe detail . Thus brief description provide . The trial approve Institutional Review Boards Human Studies Medical Faculties Johann Wolfgang Goethe-University Frankfurt/Main ( 159/06 ) University Heidelberg ( ABmu-179/2006 ) well German Federal Drug Authority ( Bundesamt für Arzneimittel und Medizinprodukte ) . All participate individual informed risk , benefit procedure study . All give write informed consent . The study register EudraCT-Nr . 2006-001367-36 number NCT01030666 . Clinical measurement The following clinical parameter assess six site per tooth ( mesiobuccal , midbuccal , distobuccal , distolingual , midlingual , mesiolingual ) baseline , 12 , 24 month surgery : Gingival Index ( GI ) , Plaque Index ( PI ) , PD CAL-V near 0.5 mm use straight manual periodontal probe ( PCPUNC 15 , Hu Friedy , Chicago , IL , USA ) . As reference CAL-V measurement , cemento-enamel junction ( CEJ ) use . If CEJ destroy restoration restoration margin ( RM ) serve reference . Radiographic examination Standardized radiograph obtain test teeth modify film holder ( VIP 2 Positioning , UpRad Corp. , Fort Lauderdale , FL , USA ) . These do routinely clinical setting , antiinfective immediately surgical treatment . Intraoral size 0 2 dental film ( Insight , Eastman Kodak Co. , Rochester , NY , USA ) expose use x-ray source ( Heliodent DS , Sirona , Bensheim , Germany ) 7 mA 60 kVp develop standardized condition ( XR24pro , Dürr Dental GmbH , Bietigheim-Bissingen , Germany ) . Radiographic evaluation All radiograph evaluate one examiner ( LR ) blind clinical result time point particular radiograph take . All radiographs digitalize use computer program ( SIDEXIS nextGeneration 1.51 , Sirona , Bensheim , Germany ) flatbed scanner ( Microtek ScanMaker 4 , Microtek , Hsinchu , Taiwan ) 600 dpi resolution 8 bit grey value . The image file store TIFF file analyze use mention computer program ( SIDEXIS nextGeneration 1.51 , Sirona , Bensheim , Germany ) 19 ' flat Screen ( Totoku CCL 192 plus , Totoku Electric , Ueda , Japan ) . For evaluation analyze tool program ( SIDEXIS nextGeneration 1.51 , Sirona , Bensheim , Germany ) use . The image file open magnified use function `` zoom '' . Then distance CEJ/RM alveolar crest ( AC ) , CEJ/RM bony defect ( DB ) , depth infrabony component ( INFRA ) measure . The definition radiographic landmark publish detail . Microbiological examination Immediately 14±2 day surgery subgingival plaque sample take test sit analyze commercially available real-time PCR test ( Meridol Paro Diagnostik , GABA GmbH , Lörrach , Germany ) Aggregatibacter actinomycetemcomitans ( A.a. ) , Porphyromonas gingivalis ( P.g . ) , Tannerella forsythia ( T.f . ) , Treponema denticola ( T.d . ) , Fusobacterium nucleatum ( F.n . ) , Prevotella intermedia ( P.i. ) . The detection limit test 10² . Periodontal Surgery Infrabony defect report analysis treat application EMD ( Emdogain® , Institut Straumann AG , Basel , Switzerland ) . Before closure defect intrasurgical parameter measure . Postsurgical Care All patient take postsurgical medication day 7 day regenerative periodontal therapy : - Test : 200 mg doxycycline - Control : 200 mg placebo . Doxycycline placebo package identically store sealed envelope mark randomization code . Patients receive doxycycline placebo regenerative surgery accomplish . Patient clinician blind . Block randomization smoking status ( current smoking : smokers/former never smoking : non smoker ) provide manufacturer doxycycline ( August Wolff GmbH &amp; Co. Arzneimittel , Bielefeld , Germany ) . Further , patient advise rinse 0.12 % chlorhexidine gluconate solution ( ParoEx , Butler , Kriftel , Germany ) 2 minute bd 5 7 week surgery . During time , patient refrain individual mechanical plaque control thus see every week control gentle cleaning teeth . In addition , 400 mg ibuprofen qd prescribe patient 's comfort necessary . If soft tissue dehiscence note patient advise use 1 % chlorhexidine gluconate gel ( Chlorhexamed 1 % Gel , GlaxoSmithKline , Bühl , Germany ) twice daily . Sutures retain long maintain closure.18 Seven 8 day surgery wound heal classify accord Early Wound-Healing Index ( EWI ) . Statistical analysis Sample size calculation base observed standard deviation CAL-V gain ( 1.6 mm ) study compare regenerative therapy without antibiotic . To detect mean difference 1.0 mm test power 80 % type 1 error alpha &lt; 0.05 minimal sample size 84 patient recruit , 42 group . Thus , decide recruit total 90 patient . The patient define statistical unit . CAL-V gain 6 month use primary bony fill 12 month secondary outcome variable . All parameter control variable . Baseline patient characteristic describe means±SD ( age , PCR ) frequencies/percentages ( sex , smoke ) . All clinical parameter calculate means±SD ( PI , GI , PD , CAL-V , INFRA ) . After control normal distribution CAL-V gain PD reduction 2 test group ( DOXY/PLAC ) compare use independent test . Intragroup comparison ( baseline/12/24 month ) calculate use paired test . Inter intragroup comparison radiographic bone , PI GI calculate use Mann Whitney U Wilcoxon test , respectively . To explore impact subgingival microflora primary secondary outcome variable compare CAL-V gain ( independent test ) 6 month bony fill ( Mann Whitney U ) 12 month therapy accord presence/absence test periodontal pathogen . A multiple regression model calculate dependent variable bony fill independent variable baseline clinical parameter ( CAL-V , PD , GI , PI ) , postsurgical medication ( DOXY/PLAC ) , defect parameter ( INFRA , % 1 , 2 , 3wall component ) , baseline A. actinomycetemcomitans , age , sex , centre , smoking , EHI . Sex , centre , smoke habit define indicator variable . All patient recruit treat accord study protocol consider analysis ( intent treat : ITT ) . If patient leave study finish re-examinations respective data last re-examination enter analysis ( last observation carry forward : LOCF ) . Statistical analysis perform use PC program ( SystatTM Windows Version 10 , Systat Inc. Evanston , IL , USA ) .</detailed_description>
	<mesh_term>Periodontitis</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Chlorhexidine gluconate</mesh_term>
	<mesh_term>Chlorhexidine</mesh_term>
	<mesh_term>Doxycycline</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Adult patient ( least 18 year age ) moderate severe periodontal disease ( chronic aggressive periodontitis ) recruit Dept . Periodontology , Centre Dental , Oral , Maxillofacial Medicine , Hospital Johann Wolfgang GoetheUniversity Frankfurt/Main Section Periodontology , Dept . Conservative Dentistry , Clinic Oral , Dental , Maxillofacial Diseases , University Hospital Heidelberg complete initial periodontal treatment consist oral hygiene instruction , scale root plan local anesthesia accord concept fullmouth disinfection evaluation tissue response patient 's plaque control 3 month later . Sites infrabony defect persist pocket ( PD &gt; 5 mm bleeding probing , BOP ) occur evaluation supportive periodontal treatment ( SPT ) subject surgical therapy . least one radiographically detectable infrabony lesion good physical health effective individual plaque control ( Fullmouthplaque score PCR &lt; /= 30 % [ O'Leary et al . 1972 ] ) interproximal angular defect singlerooted teeth multirooted teeth without furcation involvement , radiographic infrabony component &gt; /= 4 mm , vertical clinical attachment loss ( CALV ) &gt; 6 mm PPD &gt; /= 6 mm Only woman childbearing age ( &lt; 45 year ) provide contraception screen U2 inform write consent know allergy tetracycline component active drug placebo severe liver dysfunction local systemic antibiotic treatment last 3 month surgery ineffective individual plaque control ( PCR &gt; 30 % ) kidney dysfunction medication barbiturate , carbamazepin , diphenyhydantoine , sulfonylurea , methoxyflurane , ciclosporin A , theophylline , isotretionin chronic alcohol abuse anticoagulative therapy need antibiotic endocarditis prophylaxis pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>periodontal regeneration</keyword>
	<keyword>radiographic bone fill</keyword>
	<keyword>infrabony defect</keyword>
	<keyword>randomize placebo-controlled clinical trial</keyword>
	<keyword>guide tissue regeneration , periodontal</keyword>
</DOC>